Belen Elguero
Buenos Aires, C, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Expression of RSUME is Associated With Poor Prognosis in Clear Cell Renal Carcinoma: Involvement of ROS Related Metabolism.
Journal: Clinical genitourinary cancer
Published: August 16, 2022
Impact of RSUME Actions on Biomolecular Modifications in Physio-Pathological Processes.
Journal: Frontiers in endocrinology
Published: January 28, 2022
Mass Spectrometry-Based Metabolic Fingerprinting Contributes to Unveil the Role of RSUME in Renal Cell Carcinoma Cell Metabolism.
Journal: Journal of proteome research
Published: October 30, 2020
Modifications in the cellular proteome and their clinical application.
Journal: Medicina
Published: December 22, 2019
Low Doses of CPS49 and Flavopiridol Combination as Potential Treatment for Advanced Prostate Cancer.
Low Doses of CPS49 and Flavopiridol Combination as Potential Treatment for Advanced Prostate Cancer.
Journal: Current pharmaceutical biotechnology
Published: November 09, 2019
von Hippel-Lindau mutants in renal cell carcinoma are regulated by increased expression of RSUME.
Journal: Cell death & disease
Published: November 13, 2018
Low doses of CPS49 and flavopiridol combination as potential treatment for advanced prostate cancer.
Low doses of CPS49 and flavopiridol combination as potential treatment for advanced prostate cancer.
Journal: Current pharmaceutical biotechnology
Published: September 05, 2014
Unveiling the association of STAT3 and HO-1 in prostate cancer: role beyond heme degradation.
Journal: Neoplasia (New York, N.Y.)
Published: August 18, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026